Semaglutide is typically administered once weekly, while Tirzepatide offers various dosing options, including once-weekly injections
Owing to these effects, liraglutide, a GLP-1 analog, has been studied as a potential drug for the treatment of pre-eclampsia, a pregnancy specific disorder, defined as new-onset hypertension after 20th week of gestation accompanied by proteinuria, as it is found to have anti-inflammatory and antioxidative effects (89)
This metabolic flexibility, the ability to switch smoothly between burning stored fat and using incoming nutrients, is the foundation of sustained energy
Conclusion Mounjaro (Tirzepatide) is a promising treatment for Type 2 Diabetes and obesity, offering better blood sugar control and weight loss benefits